HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications-Reference-Cited by-同舟云学术

HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications

Published:2015-10 Issue:19-20 Volume:21 Page:2559-2571
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Karabekian Zaruhi¹²,Ding Hao¹,Stybayeva Gulnaz³,Ivanova Irina¹,Muselimyan Narine¹,Haque Amranul³,Toma Ian¹,Posnack Nikki G.¹,Revzin Alexander³,Leitenberg David¹,Laflamme Michael A.⁴,Sarvazyan Narine¹

Affiliation:

1. Pharmacology and Physiology Department, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia.

2. L.A.Orbeli Institute of Physiology, National Academy of Sciences, Yerevan, Armenia.

3. Department of Biomedical Engineering, University of California Davis, Davis, California.

4. Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, Washington.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2015.0105

Reference75 articles.

1. Pluripotent Stem Cells: Immune to the Immune System?

2. Immunogenicity of induced pluripotent stem cells

3. Immunogenicity of Pluripotent Stem Cells and Their Derivatives

4. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

5. The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective;Cells Tissues Organs;2023-01-04

2. Universal and hypoimmunogenic pluripotent stem cells for clinical usage;Progress in Molecular Biology and Translational Science;2023

3. The potential of cellular transplantation to harness autoimmunity and reverse clinical diabetes;Translational Autoimmunity;2023

4. Maintenance of Hypoimmunogenic Features via Regulation of Endogenous Antigen Processing and Presentation Machinery;Frontiers in Bioengineering and Biotechnology;2022-07-22

5. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells;Stem Cell Research & Therapy;2022-02-02